Clinical Trial Update: Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial updating the use of allogeneic natural killer cells in advanced metastatic breast cancer; study terminated with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Allogeneic Natural Killer (NK) Cells

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2010-08-12